Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.94%
#4 aPriori aPriori +113.84%
#5 Bedrock Bedrock +73.65%
#6 Cysic Cysic +47.27%
#7 Prom Prom +39.78%
#8 Playnance Playnance +35.16%
#9 COTI COTI +30.31%
#10 Nillion Nillion +22.86%
Coin of the day
Wrapped One Wrapped One
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Classifica tra le azioni #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Prezzo delle azioni
$0.85
Ultima sincronizzazione: 2025-01-21
Capitalizzazione di mercato
$411.40
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Fresh2 Group Limited (FRES)

Categoria

Healthcare
Utile per Fresh2 Group Limited (FRES)
Utile nel Jun 2023 TTM: $-13.66M
Secondo gli ultimi rapporti finanziari di Fresh2 Group Limited, gli utili attuali della società sono $-13.66M. Nel 2021, la società ha registrato un utile di $-18.85M, una diminuzione rispetto a agli utili del 2020, che erano di $-11.67M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Fresh2 Group Limited dal 2017 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $-13.66M -10.89%
2022 $-15.33M -18.70%
2021 $-18.85M 61.55%
2020 $-11.67M -20.14%
2019 $-14.61M 130.04%
2018 $-6.35M 7.85%
2017 $-5.89M 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -38,721.23%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -14,382.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -22,106.96%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR